Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CEO’ operating in the Health Diagnostics space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Siro Perez
Co-Founder & CEO of Molecular Warehouse
Follow Siro Perez:
About IP Group, Kira Biotech, Molecular Warehouse: Molecular Warehouse is creating a world where most diseases are prevented, by giving people the power of molecular diagnostics and mHealth.
_______
Emmanuel Ligner
President & CEO, Life Sciences of GE Healthcare
Emmanuel joined GE Healthcare in April 2008, following its acquisition of Whatman International Plc. Since 2008, Emmanuel has held various positions in GE Healthcare Life Sciences. Working both in the UK and in the US, he managed the North America BioProcess business. In January 2012, Emmanuel took charge of the Commercial part of the then Life Sciences business, across EMEA, later expanding his role to include global commercial leadership of BioProcess. In January 2016, Emmanuel was name General Manager of the Core Imaging business which he held until he was named President and CEO of Life Sciences In July 2017. Emmanuel first entered the biopharma industry in Japan, joining Ostuka Pharmaceutical International Ltd as a Medical Representative in Tokyo. After five years in Ostuka in various roles, Emmanuel joined Abbott Japan, occupying positions such as Marketing Director Diagnostic Division and Commercial Director Diabetes Care Division. After 10 years in Japan, Emmanuel moved to the UK as Vice President Sales & Marketing Europe for Whatman International Plc.
Follow Emmanuel Ligner:
About Cytiva, GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Jan Makela
President and CEO, Imaging at GE Healthcare of GE Healthcare
Jan Makela is the President & CEO of GE Healthcare Global Services. Appointed in December 2017, he oversees the global development and execution of GE Healthcare’s service solutions and operations around the globe.
Follow Jan Makela:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Kieran Murphy
President & CEO of GE Healthcare
Kieran Murphy is President and CEO of GE Healthcare, a $20 billion business unit of General Electric that provides transformational medical technologies and solutions to the global healthcare industry. GE Healthcare supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging and healthcare IT through to molecular diagnostics and life-sciences. Prior to this, Kieran was President and Chief Executive Officer of GE Healthcare Life Sciences, a $3.7 billion molecular medicine business that provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. Kieran was appointed CEO in May 2011 and oversaw significant revenue growth and geographic expansion of the molecular medicine business. Kieran joined GE Healthcare in 2008 from Whatman plc, a $230 million global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. Kieran has over twenty years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc.
Follow Kieran Murphy:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Gordon Sanghera
Chief Executive Officer, Co – founder of Oxford Nanopore Technologies
Gordon Sanghera was co-founder of Oxford Nanopore, together with Hagan Bayley and IP Group. He was appointed CEO in June 2005 having acted as a consultant since February 2005 whilst the Company was established. He brings over 15 years experience in the design, development and global launch of novel point-of-care biosensor devices. At Abbott Laboratories, Dr Sanghera held both UK and US Director level positions, including Research Director and Manufacturing Process Development Director. Before its acquisition by Abbott, Gordon led the R&D of Medisense Inc. where he was instrumental in the launch of several generations of blood glucose biosensor systems for the consumer and medical markets. He has also developed and validated market production processes to meet with the regulatory requirements for USA and Europe. Gordon has a DPhil in biosensor technology and a degree in Chemistry.
Follow Gordon Sanghera:
About Oxford Nanopore Technologies: Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Jean-luc Bressard
CEO of Hextransforma Healthcare
Social equality campaigner and entrepreneur
Follow Jean-luc Bressard:
About Dolerite Ltd, Hextransforma Healthcare, Time to Shine Kids: Telemedicine and digital healthcare solution provider. Owner of the Brit-Med.com medical tourism platform
Mayank Banerjee
Co-Founder and CEO of Even
Mayank Banerjee joined Even Healthcare as Co-Founder in 2020.
Follow Mayank Banerjee:
About Even: Even is a health-tech company and healthcare provider that partners directly with the top hospitals in the country.
Avi Lasarow
CEO Europe, Middle East & Africa of Prenetics
Avi Lasarow is a multiple award-winning South African entrepreneur referred to by the media as ‘a lifestyle genetics pioneer’ known for his work associated with DNA testing. Avi is currently founder and CEO of genetic testing company DNAFit Life Sciences, which conducted the worlds 1st peer-reviewed and published clinical trial using both genetics and exercise interventions. In 2011 he became the youngest person to be appointed Honorary Consul for South Africa to the United Kingdom by His Excellency President Jacob Zuma. Avi was recently named African Businessman of the year in London at the African Enterprise Awards, his company DNAFit has won numerous awards, including the Lloyd’s Bank National Business Award for Innovation of the Year in 2015, winner at the UKActive Flame Awards and an award for Innovation at the South African Chamber Awards. Most recently, DNAFit was named as one of Fast Company’s Most Innovative in the field of Data Science.
Follow Avi Lasarow:
About DNAFit, Prenetics: Prenetics is a genetic and diagnostic health testing company that helps identify health risks with the use of a DNA sequencing technology.
Connor Campbell
Founder and CEO of Osler Diagnostics
Follow Connor Campbell:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Matteo Berlucchi
CEO & Co-Founder of Healthily by Your.MD
Matteo’s digital career spans 20 years, during which he has conceived, built and launched several successful companies and services both online and on mobile. Most recently, Matteo was Chief Digital Officer at Northern & Shell, the largest independent media company in the UK,where he grew traffic and revenues 4-fold in just 12 months. Matteo was also the founder and CEO of aNobii, the ebook platform funded by Penguin Random House, HarperCollins which was acquired by Sainsbury’s in 2012. Matteo founded Livestation, the leading service for live TV news online and the first company in the world to stream live TV on iPhones. Livestation is also the winner of the Guardian Digital Innovation Award 2008. Prior to this, Matteo was CEO and co-founder of Skinkers, a software company, which defined the market for desktop widgets and the winner of several international innovation awards in the digital space. Matteo started his career by launching the first online property system in Europe in 1995.
Follow Matteo Berlucchi:
About Healthily by Your.MD, Vini Italiani: Healthily is the world’s first medically approved self-care app designed around you.
Aron Rachamim
Founder & CEO of Senzo
Aron Rachamim is committed to changing the world by putting healthcare information into everyone’s hands. A serial entrepreneur, scientist, and experienced leader, Aron aims to apply pioneering technologies to improve people’s quality of life. His expertise and passion for the science of microfluidics builds on his background in life sciences, physics, and engineering. His company Orphidia intends to transform the world of medical diagnostics. Aron launched Orphidia in 2013 to provide affordable, point-of-care diagnostics that allow everyone to know their health. Orphidia has advanced the state-of-the-art with microfluidic-based medical diagnostics that are minimally invasive, replacing venous blood draws from a phlebotomist with a simple fingerstick that anyone can perform. Aron is a serial entrepreneur, whose background combines a PhD from the University of Cambridge and a focus on microfluidics and biotechnology with strong experience in professional management. At Protein Logic, a spin-out from Cambridge University that raised more than £3 million in initial funding to develop proprietary biomarker technology for the diagnosis and prediction of diseases, he served as COO. At WiseMed, where he was Co-founder, his team developed crowdsourced medical diagnostic technology as an affordable solution for improving healthcare in the developing world. Now, at Orphidia, Aron is providing the vision and leadership that will usher in the next generation of medical diagnostics, empowering everyone to know their health.
Follow Aron Rachamim:
About Senzo: Senzo is a deep-tech bio-med company developing testing products and IP.
Melinda Nicci
Founder and CEO of Baby2Body
Melinda is founder and CEO of Body Collective (Baby2body) the award- winning, wellness company for women.
She is a Sports and Exercise Psychologist, author of two bestselling books, is a regular contributor on the BBC, and sits on numerous boards as a NED, including The ICE List and Team GB (Olympic and Para-olympics snow-sport teams).
Melinda was named the UKBAA High Growth Founder of the year 2019/20, and has won numerous accolades and awards for entrepreneurship, including being named in the UK list of the Most Influential Women in Tech for 4 years running.
A serial entrepreneur, she founded and sold her first business at the age of 25 in South Africa, and held the position of Senior Director for Consumer health Innovation at Philips in Amsterdam. Melinda brings her passion for sport, performance and wellness to the numerous companies she advises and has created a global business with Body Collective, helping millions of women all over the world to live healthier and happier lives.
Follow Melinda Nicci:
About Baby2Body, GB Snowsport, ICE List: Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Emi Gal
Co-founder & CEO of Ezra AI
Emi Gal is a co-founder of Brainient, a video advertising technology company. Prior to launching the startup in 2009, Gal started two other companies and was involved with various technology and internet startups, including Skimlinks (UK), eOk (Romania) and SkinScan (Romania). Gal occasionally speaks at various entrepreneurship and technology events, writes for The Telegraph and TechCrunch Europe, and has a strong interest in technology and education. He is also a board director on the Board of Romanian seed fund, Digital Catalyst Fund. He has been named in Forbes Romania Top 30 Under 30 (2012) and SquareMile Magazine’s Top 30 Under 30 (2011), and was the Seedcamp winner in 2009. Gal loves experiments, tennis, swimming, books and chocolate.
Follow Emi Gal:
About Ezra AI, Zeno Wearables: Ezra AI provides early cancer detection by combining advanced medical imaging technology and AI technology.
Khoa Phan
CEO & Co-Founder of Backbone Labs, Inc.
Khoa’s entrepreneurial spirit and engineering experience drives the strategic vision of Backbone Labs, as well as the development of its products. Before he launched Backbone Labs, Khoa founded a successful marketing agency specializing in search, content and social media ad campaigns for acquiring customers and users. He has also co-founded an indie mobile game studio. When he’s not building companies, Khoa is an avid collector of rare sneakers.
Follow Khoa Phan:
About Backbone Labs, Inc.: Identify at-risk behavior in the workplace and recommend actions to promote and maintain overall back-related wellness.
Abdullah Sabyah
Founder and CEO of Rightangled
A scientist-entrepreneur and a healthcare professional, also a member of the British Heart Foundation Alliance, a member of the Clinical Pharmacogenomics Implementation Consortium in the US, and the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay (the patent is for a technology to detect DNA sequences in real-time).
Follow Abdullah Sabyah:
About Rightangled: Medtech specialised in Genetics, Blood and infection testing. Service is delivers through a platform that connects users with specialists.
Sina Habibi
CEO of Cognetivity Neurosciences
Sina Habibi is the CEO at Cognetivity Neurosciences.
Follow Sina Habibi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Bobby Gaspar
Chief Executive Officer of Orchard Therapeutics
Bobby is Professor of paediatrics and immunology at the UCL Institute of Child Health and Honorary Consultant in paediatric immunology at Great Ormond Street Hospital, London. He has a special interest in the treatment of severe primary immune deficiencies, including bone marrow transplantation, gene and cell therapy. He has led multiple clinical trials that have shown that gene therapy can successfully correct the genetic defect in immune deficiencies. Bobby is currently leading UK and European-wide initiatives for newborn screening in severe combined immune deficiency. He is Director of the Centre for Research in Rare Diseases in Children (CRRDC), a new academic and clinical facility that will open at Great Ormond Street in 2018.
Follow Bobby Gaspar:
About Orchard Therapeutics: Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.
Ali Parsa
Founder and CEO of Babylon
Ali is an entrepreneur and engineer. He built Circle to become Europe’s largest partnership of clinicians, achieving around £200M in annual revenue, 3000 employees and a successful IPO, all during an economic recession. He was named by The Times as among the 100 global people to watch, and was the recipient of the Royal Award for young entrepreneurs for founding V&G earlier in his career. Ali is a UK Cabinet Office Ambassador and has a PhD in engineering Physics.
Follow Ali Parsa:
About Babylon: Babylon is a world leading, digital-first, value-based care company.
David Meinertz
CEO of Zava
David Meinertz (born 1974) is CEO of Europe’s largest online doctor Zava (previously DrEd). He founded Zava with Amit Khutti in 2010. Since the start of service in 2011 Zava has treated over three million patients across six European countries. Before Zava, the entrepreneur was responsible for the international expansion of a leading telemedicine company in the UK, and held a senior position in a European investor focused on small to mid-sized companies in the field of healthcare, technology and distribution. Meinertz is a lawyer and graduated with an MBA from HEC Paris. Together with his wife and three sons he lives in London.
Follow David Meinertz:
About Zava: Zava is an online medical service provider and offers consultations, diagnostics and medication without the need for a face-to-face visit.
Yeshwanth Pulijala
Founder & CEO of Scalpel
Follow Yeshwanth Pulijala:
About Scalpel: Scalpel provides a platform to optimize surgical procedures in clinics and hospitals.
Emilio Sanz Pereiras
CEO of Acurable
Emilio is a serial entrepreneur and leads Acurable’s strategy, operations and commercialisation activities. Emilio spent the last 15 years building 3 successful start-ups across Europe and Asia, where he learned first hand how to successfully commercialise highly innovative technologies and how to to scale start-up operations in both B2B and B2C industries. Originally from Spain, Emilio holds a MSc in Electrical Engineering from Telecom ParisTech, a MSc in Computer Science from the Polytechnic University of Madrid and an MBA from London Business School.
Follow Emilio Sanz Pereiras:
About Acurable: The first wearable medical device able to accurately diagnose and manage respiratory conditions at home
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Fouad Al Noor
Co-Founder & CEO of ThinkSono
Fouad has a masters in Electronic Engineering with Nanotechnology from the University of Southampton. He worked as a research assistant at Imperial College London before joining Entrepreneur First. He wrote his thesis on paper-based medical diagnostics using image processing.
Follow Fouad Al Noor:
About ThinkSono: Cutting edge AI ultrasound software for detection of blood clots (DVT)
Paul Cowan
Founder , Chairman & Chief Executive Officer of Quotient Biodiagnostics
Paul Cowan is our Chief Executive Officer and Chairman of our Board of Directors. Mr. Cowan founded us through the acquisition of Alba Bioscience in 2007. He has a broad range of healthcare industry experience gained through over 15 years of employment within industry and investment banking. Previously, Mr. Cowan served as the Chief Financial Officer of Inveresk Research Group, a global contract research organization that was acquired by Charles River Laboratories in 2004. Prior to joining Inveresk in 2001, Mr. Cowan was a senior executive within the Investment Banking department of Bear Stearns & Co., where he led the European biotechnology practice. Prior to Bear Stearns, Mr. Cowan was a senior executive within the Investment Banking department of Morgan Grenfell (acquired by Deutsche Bank in 1990). Mr. Cowan received a Bachelor of Business in accounting from Queensland University of Technology.
Follow Paul Cowan:
About Quotient Biodiagnostics: Quotient Biodiagnostics develops and manufactures products for use in transfusion diagnostics.
Harry lamble
CEO of Sense Biodetection
Follow Harry lamble:
About Sense Biodetection: Sense Biodetection Limited is a molecular diagnostics company .
Wais Shaifta
Chief Executive Officer of Push Doctor
Wais Shaifta is the chief executive officer of Push Doctor.
Follow Wais Shaifta:
About Push Doctor: Push Doctor is creating the future of healthcare.
Ronan Cunningham
Founder and Chief Executive Officer of BrainWaveBank
Ronan has more than 20 years of experience in advanced engineering and product development. He was one of the founding members of ATA Engineering, an award-winning San Diego-based engineering company specializing in development of innovative hardware and software technologies for the aerospace and defence industries. His roles have included Director of Business Development and Director of New Technology Development. He is an Entrepreneur-in-Residence with the Northern Ireland Science Park. His expertise is in early stage technology development, innovation strategy, and technology commercialisation. He holds an MS in Aeronautics and Astronautics from MIT.
Follow Ronan Cunningham:
About BrainWaveBank, Cumulus Neuroscience: BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.
Himanshu Kataria
Founder, CEO and Managing Director of CLYZ Labs
Himanshu is an experienced NHS Academic Clinician with emergency medicine background (>10 years clinical experience). Himanshu has substantial experience in setup and delivery of clinical research trials, as a specialty lead within Clinical Research Network for the whole of North West Coast of England delivering research in >23 NHS Partner organisations. Himanshu is an MBBS, MBBS, MRCSed (A&E), MRCEM, FRCEM, ALS Instructor. With a number of years in both clinical and research experience, Himanshu has held various consultancy posts in notable hospitals/medical facilities such as Whiston Hospital in Merseyside. He also held the Special Group Lead position within the Clinical Research Network – North West Coast: Research Delivery arm of the NIHR (National Institute of Health Research). In addition to his qualifications as a Medical Doctor, Himanshu has held a number of entrepreneurial roles over the past few years in bio-medical companies such as Indu Stem Cell Technology Plc, and Transgenex Inc in the USA. Dr Kataria is familiar with financial management of the business owing to his experience in Clinical Finance Limited which advised for fundraising for Indu Stem Cell Technology PLC. He continues to serve as a director for Indu Stem Cell Technology PLC.
Follow Himanshu Kataria:
About CLYZ Labs: CLYZ Labs are developing a testing service to select the best drug therapy for personalised cancer treatment.
Lukas Lange
CEO and Co-Founder of Probably Genetic
Follow Lukas Lange:
About Probably Genetic: Probably Genetic helps rare genetic disease patients.
Manuel Llobet
CEO of Allergy Therapeutics
Manuel Llobet joined the Company in September 2009 following the successful refinancing by Azure Ventures Limited. Prior to this appointment, Manuel was the Principal Consultant for Biohealth LLC and CEO of International Operations of the Weinstein family’s group of companies. Mr Llobet was responsible for international development of the Weinstein family’s group of pharmaceutical companies in 20 countries. Mr Llobet has over ten years experience working in the pharmaceutical industry, primarily in South America and has served as Executive Director of Coporación Drokasa where he was responsible for a US$25 million AAA-rated bond issue to finance the group’s expansion plans; CEO of Laboratorios Andrómaco where he led the Company to an IPO on the Santiago Stock Exchange; and Business Development Manager for Laboratorio Chile. Mr Llobet participated in the Executive Program at the Graduate Business School of Stanford University and has an MBA from IESE, Universidad de Navarra, Barcelona. Mr Llobet also has degrees in Industrial Business Management and Chemical Engineering from Universitat Ramon Llull, Barcelona.
Follow Manuel Llobet:
About Allergy Therapeutics: Allergy Therapeutics (AT) is a European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy.
Silja Litvin
Founder & CEO of PsycApps
I am a London based Psychologist, CEO and Founder of the Mental Health platform PsycApps. The mental health platform is also part of my PhD thesis in clinical psychology at the Ludwig Maximilian University (LMU) of Munich with help of Oxford University College. • In 2013 I finished my Masters in Psychology from LMU majoring in Family and Clinical Psychology. • As aforementioned I am currently completing my postgraduate education as a PhD student of the LMU with help of University College, Oxford. To help raise awareness for both mental well-being in general and our products, I speak at conferences and mental health panels. Being half German, half American, I speak fluent English and German. My French is decent and I understand Italian quite well. Because of my modelling career I am well-traveled, culturally diverse and I am by nature an extroverted people person. Media (1)This position has 1 media
Follow Silja Litvin:
About PsycApps, PsycApps, UCL, Wonder Women Tech: Digital Mental Health Games
Terry Pizzie
Chief Executive Officer of Horizon Discovery
Terry became Chief Executive Officer in May 2018 having joined Horizon Discovery Group in February 2017 as Head of Commercial Operations. He has amassed more than 30 years of commercial experience within the biotechnology tools sector. He started his career with Applied Biosystems in 1988 in a sales role and became Vice President of Europe in 2003. Terry went on to join the Swedish biotechnology firm Biacore in 2005 as SVP Global Commercial Operations and was part of the team that reignited the company’s commercial success, culminating in its acquisition by GE Life Sciences. After a period with Genetix PLC as Director, Global Commercial Operations prior to its acquisition by Danaher, Terry went on to head global sales at Pacific Biosciences. Terry graduated with a degree in Physiology and Biochemistry from the University of Reading and since then has spent most of his working life focused upon commercial excellence within the sector.
Follow Terry Pizzie:
About Horizon Discovery: Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Neel Patel
Founder & Chief Executive Officer of ZiO Health
Follow Neel Patel:
About ZiO Health: ZiO Health has developed proprietary pocket-sized technology, bringing lab testing to the point of use.
Ross Upton
CEO of Ultromics
Ross is specialised in utilising computational technologies to build diagnostic algorithms within cardiovascular imaging. Ross has a strong academic background within the medical sciences and has undertaken two MSc degrees and a DPhil, receiving multiple grants for technology innovation and being selected as finalist for the 2015 Young Investigator Award in Lisbon. Together with Professor Leeson, Ross founded Ultromics’ underlying technology and as CEO, he drives all aspects of the company from technology development to business strategy.
Follow Ross Upton:
About Ultromics: Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
Jean Viry-Babel
CEO, Board Member of xRapid
Follow Jean Viry-Babel:
About xRapid: xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Giovanna Forte
Founding Director & CEO of Forte Medical
Giovanna is credited within bringing her GP brother’s invention to life. She invested personally in his idea, to explore design and material R&D, secure IP rights and ultimately attract investment from the GLA Early Growth Fund in 2006. As CEO she realised the successful launch of Peezy Midstream, established credible clinical evidence, developed PR, marketing, sales campaigns and has overseen the ongoing investment needs of the business. Specimen collection is arguably the most basic procedure required for analysis, diagnosis and treatment of myriad conditions; Giovanna’s desire to improve these often messy processes drove engagement with clinicians, microbiologists and patients. Her inquiry and love of good design has led to development of The Specimen Collection.
Follow Giovanna Forte:
About Forte Medical: Forte Medical is a diagnostic center in London, England.
Hugh Cormican
CEO of Cirdan
Hugh, a founder of Cirdan, studied physics at Queens University Belfast. Also a founder and Director of Andor Technologies Plc, he was awarded an Honorary Doctorate by QUB in 2003. During his PhD studies Hugh became involved in the start-up of Andor Technology. In 2000 he was awarded the Institute of Physics Paterson medal and prize for commercialization of Physics in recognition of the success of Andor.
Follow Hugh Cormican:
About Cirdan: Cirdan delivers solutions that enable rapid implementation of a robust and scalable digital pathology workflow into a laboratory.
Arron Tolley
Chief Executive Officer of Aptamer Group
Arron holds a Ph.D. in Molecular Biology and Biophysics from the University of Leeds and has a B.Sc. in Molecular Medicine. Arron has several years’ experience raising aptamers against complex cellular targets and model disease systems. He has developed several aptamer panels against model cell lines associated with oesophageal adenocarcinoma. These have shown promise for use as cell imaging reagents, biomarker discovery tools and as novel therapeutics. Arron still plays an active role in the R&D side of the group and is credited with the invention and development of a new aptamer based biomarker discovery platform (Aptasort) to be offered to the life sciences industry through the aptamer group.
Follow Arron Tolley:
About Aptamer Group: Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.
Graham Mullis
Chief Executive Officer of NOVACYT
A healthcare experienced CEO who has the skills to develop and commercialise new technologies, build high growth, successful businesses and create shareholder value. Extensive international experience including living and working in the US, Ireland and Singapore. Includes significant M&A experience from targeted roll-up strategies. Building high performing teams is both rewarding and fun.
Follow Graham Mullis:
About NOVACYT: NOVACYT develops cellular diagnostics with a growing portfolio of cancer and infectious disease products and services.
Chris Ball
Chief Executive Officer of Jupiter Diagnostics
Prior to founding Jupiter Diagnostics, Chris launched point-of-care diagnostic tests for Johnson & Johnson in Europe. He has worked as a CEO of a Boston biotech company, as a venture capital investor and a doctor. He has raised more than £40 million for companies he has supported or led.
Follow Chris Ball:
About IQVIA, Jupiter Diagnostics: Jupiter Diagnostics has developed a diagnostic platform
Ashmita Das
Co-founder and CEO of Kolabtree
Follow Ashmita Das:
About Kolabtree: Find & hire experts, top postdocs & PhDs, as research collaborators for your academic or business projects.Speed up your research work!
Jonathan Allis
Co-Founder & CEO of Blue Earth Diagnostics
Jonathan Allis is the founding CEO of Blue Earth Diagnostics. Prior to this role, Jonathan was the General Manager for PET at GE Healthcare Life Sciences, and had global responsibility for GE Healthcare’s PET agent and PET synthesis platforms business. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc., Siemens Medical Solutions and Oxford Magnet Technology, in the UK, USA and Germany. Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in biochemistry from the University of Oxford.
Follow Jonathan Allis:
About Blue Earth Diagnostics: BlueEarth Diagnostics mission is to transform the clinical management of recurrent prostate cancer
Neciah Dorh
Co-Founder and CEO of FluoretiQ
Neciah Dorh is a Co-Founder and serves as the Chief Executive Officer at FluoretiQ.
Follow Neciah Dorh:
About FluoretiQ: FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
David Cole
Chief Executive Officer of Vanguard Healthcare Solutions
A mental health nurse by training, David brings with him the benefits of more than 35 years of experience in the health and social care sector. Prior to joining Vanguard, David was CEO at Cygnet Health Care, one of the UK’s largest operators of specialist mental health services. He has also chaired Choice Care Group, Lighthouse Healthcare and Glenside Care Group. He was CEO of Castlebeck between 2003 and 2007. He has served on the Board of Frosunda, a specialist Swedish care operator, and has acted as an advisor to a wide range of healthcare organisations, including Advent International. David understands the complexities of regulated healthcare operations, customer expectations, and the need to innovate and develop products to help progress the market. Combining this knowledge with his significant experience of successfully leading and growing healthcare organisations, he is well placed to lead Vanguard Healthcare Solutions in its UK and increasingly international operations.
Follow David Cole:
About Vanguard Healthcare Solutions: Vanguard Healthcare Solutions operates a fleet of mobile healthcare facilities that support National Health Service & healthcare providers.
Nadia Whittley
Chief Executive Officer of Arquer Diagnostics
Follow Nadia Whittley:
About Arquer Diagnostics: Arquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test.
Julian Huw Baines
CEO of EKF Diagnostics
Julian Huw Baines serves as the chief executive officer and executive director of EKF Diagnostics Holdings. He also formerly served as a director at Quotient Diagnostics Ltd.
Follow Julian Huw Baines:
About EKF Diagnostics: EKF Diagnostics manufactures point of care equipment for measuring glucose, lactate, hemoglobin, hematocrit, and glycated hemoglobin
Jon Holmes
Co-Founder and CEO of Michelson Diagnostics
Under Jon’s skilful and visionary leadership, Michelson Diagnostics Ltd has rapidly grown from a fledgling start-up in 2006, to the thriving company it is today. He has masterminded five rounds of investment, and his strategy for growth has enabled the company to achieve all of its milestones to date, on time and on budget.Jon was previously Business Director of the Biomedical Group at Sira, the instrumentation R&D company, and was Director of the Smart Optics Faraday Partnership.
Follow Jon Holmes:
About Michelson Diagnostics, Michelson Diagnostics, SmartOptics: Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography-based products.
Mark Street-Docherty
Chief Executive Officer of MicrosensDx
Follow Mark Street-Docherty:
About MicrosensDx: MicrosensDx focuses on delivering the sample result in molecular solutions that transforms patient outcomes.
Billy Boyle
CEO and Co-Founder of Owlstone Nanotech
Since co-founding Owlstone, Billy has been overseeing the development and implementation of the detection technology with nanotechnology foundry partners. He is also active in business development, demonstrating to partners how the Owlstone technology can used to realise a paradigm shift in detection applications and deployment scenarios. Billy is heavily involved in the creation and realisation of new technologies and IP. Prior to joining Owlstone Billy was a Research Associate in the Microsystems and Nanotech group at Cambridge University. In an academic / industry consortium he designed and developed silicon-opto hybrid devices for next generation telecoms systems.
Follow Billy Boyle:
About Owlstone Nanotech: OWLSTONE is a platform technology, where regardless of the application, hardware remains the same & the app is enabled through software.
Richard Hancock
Chief Executive Officer of Blue Maestro
Richard Hancock joined Blue Maestro as Chief Executive Officer in 2012.
Follow Richard Hancock:
About Blue Maestro: Environment and health monitoring solutions from developing innovative Bluetooth devices to hosting a cloud platform for sensor telemetrics.
Julie Barnes
Founder/ Chief Scientific Officer & Chief Executive Officer of Abcodia
Julie has over 20 years experience of the Pharmaceutical and Biotechnology industry, including 15 years experience of early R&D with GlaxoSmithKline. More recently Julie was director and Chief Scientific Officer at BioWisdom, a healthcare technology company. Her mix of scientific and commercial experience in large pharmaceutical and small start-ups and academic network brings a strong understanding of what is required to successfully lead Abcodia as an ethical and collaborative organisation.
Follow Julie Barnes:
About Abcodia: Abcodia is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.
Andrew Baker Campbell
CEO of LEX Diagnostics
Andrew Baker-Campbell is the CEO of LEX Diagnostics.
Follow Andrew Baker Campbell:
About LEX Diagnostics: LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
Andrew Baker Campbell
CEO of LEX Diagnostics
Andrew Baker-Campbell is the CEO of LEX Diagnostics.
Follow Andrew Baker Campbell:
About LEX Diagnostics: LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
